JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265565

Human TMEM30A (Transmembrane protein 30A) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TMEM30A KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 7 bp deletion in exon 1 and Insertion of the selection cassette in exon 1.

View Alternative Names

C6orf67, CDC50A, Cell cycle control protein 50A, FLJ10856, P4 ATPase flippase complex beta subunit TMEM30A, TMEM30A

2 Images
Sanger Sequencing - Human TMEM30A (Transmembrane protein 30A) knockout HeLa cell line (AB265565)
  • Sanger seq

Unknown

Sanger Sequencing - Human TMEM30A (Transmembrane protein 30A) knockout HeLa cell line (AB265565)

Allele-2 : Insertion of the selection cassette in exon 1.

Sanger Sequencing - Human TMEM30A (Transmembrane protein 30A) knockout HeLa cell line (AB265565)
  • Sanger seq

Unknown

Sanger Sequencing - Human TMEM30A (Transmembrane protein 30A) knockout HeLa cell line (AB265565)

Allele-1 : 7 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 7 bp deletion in exon 1 and Insertion of the selection cassette in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265565-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265565 Human TMEM30A (Transmembrane protein 30A) knockout HeLa cell line", "number":"AB265565-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265565-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265565 Human TMEM30A (Transmembrane protein 30A) knockout HeLa cell line", "number":"AB265565-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TMEM30A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Transmembrane protein 30A also known as TMEM30A has an important role in cellular function as a component of the cell membrane. It is a 31 kDa protein that facilitates the transportation of certain lipids from the outer to the inner leaflets of the plasma membrane functioning as a chaperone alongside other transporters. TMEM30A shows expression in various tissues with notable levels in the brain heart and kidney reflecting its diverse cellular roles in different organ systems.
Biological function summary

TMEM30A is critical in maintaining lipid asymmetry in cell membranes. It acts within a larger complex with flippases such as ATP11 and ATP8 proteins enabling the efficient translocation of phospholipids. This activity affects membrane curvature and flexibility which is essential for cellular processes like vesicle formation endocytosis and maintenance of membrane integrity. Disruption in TMEM30A function can result in altered cellular homeostasis impacting cell viability and signaling.

Pathways

TMEM30A plays a significant part in the phospholipid flipping pathway chiefly interacting with ATP11C in energizing the lipid translocation process. This pathway is fundamental for activities like signal transduction and apoptosis where these lipids serve as substrates or signaling molecules. The protein also interrelates with the calcium signaling pathway wherein altered phospholipid distribution can influence calcium ion channels therefore impacting cellular responses and homeostasis.

TMEM30A has associations with neurological disorders and cardiovascular diseases. Disturbances in its function link closely with Alzheimer's disease where phosphatidylserine asymmetry is compromised affecting neuronal communication. TMEM30A is also relevant in the context of heart failure interacting with proteins like ATP8A1 where improper lipid transport can impair cardiac function. Dysregulation of these pathways due to TMEM30A mutations highlights its importance in maintaining physiological health.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com